<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36948447</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3511</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title><ISOAbbreviation>Int J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Back to the future of viruses: a case of triple coinfection caused by respiratory syncytial virus, human coronavirus OC43, and rhinovirus.</ArticleTitle><Pagination><StartPage>205</StartPage><EndPage>207</EndPage><MedlinePgn>205-207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2023.03.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1201-9712(23)00101-7</ELocationID><Abstract><AbstractText>We present the case of an 81-year-old man, who was immunocompetent, who was admitted to the hospital with symptoms of fever and dyspnea suspected to be caused by COVID-19. Further examination revealed a triple coinfection, as determined by multiplex polymerase chain reaction testing, caused by the respiratory syncytial virus, human coronavirus OC43, and rhinovirus. Upon auscultation, diffuse wheezing without crackles was detected. After ruling out the possibility of acute heart failure with pulmonary edema, the patient was treated with nebulization of terbutaline for a period of 72 hours. This case serves to demonstrate the potential dangers of lifting barrier measures, such as mandatory face masks in high-risk areas, during the fall-winter season. In addition, it highlights the challenges that may arise in the post-COVID-19 era because reliance on flu vaccinations alone may not be sufficient.</AbstractText><CopyrightInformation>Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davido</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Maladies infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, 92380 Garches, France; INSERM UMR1173, Université Versailles-Saint-Quentin Paris Saclay, 78180 Versailles, France. Electronic address: benjamin.davido@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaffal</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Maladies infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, 92380 Garches, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gault</LastName><ForeName>Elyanne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>INSERM UMR1173, Université Versailles-Saint-Quentin Paris Saclay, 78180 Versailles, France; Laboratoire de Virologie, Université Paris-Saclay, AP-HP Hôpital Ambroise Paré, 92100 Boulogne Billancourt, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourlet</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Maladies infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, 92380 Garches, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaune</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>INSERM UMR1173, Université Versailles-Saint-Quentin Paris Saclay, 78180 Versailles, France; Service des Urgences, Université Paris-Saclay, AP-HP Hôpital Ambroise Paré, 92100 Boulogne Billancourt, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int J Infect Dis</MedlineTA><NlmUniqueID>9610933</NlmUniqueID><ISSNLinking>1201-9712</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028962" MajorTopicYN="Y">Coronavirus OC43, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Influenza</Keyword><Keyword MajorTopicYN="N">RSV</Keyword><Keyword MajorTopicYN="N">Rhinovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36948447</ArticleId><ArticleId IdType="pmc">PMC10028211</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2023.03.024</ArticleId><ArticleId IdType="pii">S1201-9712(23)00101-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nguyen-Van-tam JS, O'leary M, Martin ET, Heijnen E, Callendret B, Fleischhackl R, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 2022;31:88–100. doi: 10.1183/16000617.0105-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0105-2022</ArticleId><ArticleId IdType="pmc">PMC9724807</ArticleId><ArticleId IdType="pubmed">36384703</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinón-Torres F, Carmo M, Platero L, Drago G, López-Belmonte JL, Bangert M, et al. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study. BMC Infect Dis. 2022;22:759. doi: 10.1186/s12879-022-07745-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07745-0</ArticleId><ArticleId IdType="pmc">PMC9520861</ArticleId><ArticleId IdType="pubmed">36175846</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control. RSV virus expected to add pressure on hospitals in many EU/EEA countries this season, https://www.ecdc.europa.eu/en/news-events/rsv-virus-expected-add-pressure-hospitals-many-eueea-countries-season; 2022 [accessed 29 March 2023].</Citation></Reference><Reference><Citation>Li Y, Pillai P, Miyake F, Nair H. The role of viral co-infections in the severity of acute respiratory infections among children infected with respiratory syncytial virus (RSV): a systematic review and meta-analysis. J Glob Health. 2020;10 doi: 10.7189/JOGH.10.010426.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/JOGH.10.010426</ArticleId><ArticleId IdType="pmc">PMC7295447</ArticleId><ArticleId IdType="pubmed">32566164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranadheera C, German GJ, Steven L, Eung D, Lyubashenko D, Pepin JC, et al. A four specimen-pooling scheme reliably detects SARS-CoV-2 and influenza viruses using the BioFire FilmArray Respiratory Panel 2.1. Sci Rep. 2022;12:4947. doi: 10.1038/s41598-022-09039-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09039-6</ArticleId><ArticleId IdType="pmc">PMC8942994</ArticleId><ArticleId IdType="pubmed">35322125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolossa T, Tsegaye R, Shiferaw S, Wakuma B, Ayala D, Bekele B, et al. Survival from a triple co-infection of Covid-19, hiv, and tuberculosis: a case report. Int Med Case Rep J. 2021;14:611–615. doi: 10.2147/IMCRJ.S326383.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IMCRJ.S326383</ArticleId><ArticleId IdType="pmc">PMC8421329</ArticleId><ArticleId IdType="pubmed">34512043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Martínez Y, Mogollón-Vargas JM, López-Rodríguez M, Rodriguez-Morales AJ. A fatal case of triple coinfection: COVID-19, HIV and tuberculosis. Travel Med Infect Dis. 2021;43 doi: 10.1016/j.tmaid.2021.102129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2021.102129</ArticleId><ArticleId IdType="pmc">PMC8223034</ArticleId><ArticleId IdType="pubmed">34174407</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolasco S, Vitale F, Geremia A, Tramuto F, Maida CM, Sciuto A, et al. First case of monkeypox virus, SARS-CoV-2 and HIV co-infection. J Infect. 2023;86:e21–e23. doi: 10.1016/j.jinf.2022.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.08.014</ArticleId><ArticleId IdType="pmc">PMC9389837</ArticleId><ArticleId IdType="pubmed">35995308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemarie B, Boussaid G, Gault E, Prigent H, Beaune S, Moreau F, et al. Predictors of hospitalization and superinfection in viral respiratory tract infections between influenza and paramyxoviruses: the SUPERFLUOUS study. J Infect Dis. 2022;226:1027–1035. doi: 10.1093/INFDIS/JIAB525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAB525</ArticleId><ArticleId IdType="pubmed">34636898</ArticleId></ArticleIdList></Reference><Reference><Citation>Haney J, Vijayakrishnan S, Streetley J, Dee K, Goldfarb DM, Clarke M, et al. Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles. Nat Microbiol. 2022;7:1879–1890. doi: 10.1038/s41564-022-01242-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01242-5</ArticleId><ArticleId IdType="pubmed">36280786</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Z, Li X, Korsten K, Bont L, Butler C, Wildenbeest J, et al. Economic burden and health-related quality of life of respiratory syncytial virus and influenza infection in European Community-dwelling older adults. J Infect Dis. 2022;226:S87–S94. doi: 10.1093/infdis/jiac069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac069</ArticleId><ArticleId IdType="pubmed">35961055</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Warren JL, Shapiro ED, Pitzer VE, Weinberger DM. Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups. Pneumonia (Nathan) 2022;14:6. doi: 10.1186/s41479-022-00098-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41479-022-00098-x</ArticleId><ArticleId IdType="pmc">PMC9592130</ArticleId><ArticleId IdType="pubmed">36280891</ArticleId></ArticleIdList></Reference><Reference><Citation>Comte A, Bour JB, Darniot M, Pitoiset C, Aho-Glélé LS, Manoha C. Epidemiological characteristics and clinical outcomes of human rhinovirus infections in a hospitalized population. Severity is independently linked to RSV coinfection and comorbidities. J Clin Virol. 2020;125 doi: 10.1016/j.jcv.2020.104290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104290</ArticleId><ArticleId IdType="pubmed">32135487</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelia Y, Procop GW, Richter SS, Worley S, Liu W, Esper F. Dynamics and predisposition of respiratory viral co-infections in children and adults. Clin Microbiol Infect. 2021;27 doi: 10.1016/j.cmi.2020.05.042. 631.e1–6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.05.042</ArticleId><ArticleId IdType="pubmed">32540470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SH, Clipman SJ, Wesolowski A, Solomon SS. Holiday gatherings, mobility and SARS-CoV-2 transmission: results from 10 US states following Thanksgiving. Sci Rep. 2021;11:17328. doi: 10.1038/s41598-021-96779-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96779-6</ArticleId><ArticleId IdType="pmc">PMC8405672</ArticleId><ArticleId IdType="pubmed">34462499</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez A, Lively JY, Curns A, Weinberg GA, Halasa NB, Staat MA, et al. Respiratory virus surveillance among children with acute respiratory illnesses – New Vaccine Surveillance Network, United States, 2016–2021. MMWR Morb Mortal Wkly Rep. 2022;71:1253–1259. doi: 10.15585/mmwr.mm7140a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7140a1</ArticleId><ArticleId IdType="pmc">PMC9541034</ArticleId><ArticleId IdType="pubmed">36201373</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroux-Roels I, Davis MG, Steenackers K, Essink B, Vandermeulen C, Fogarty C, et al. Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase I/II randomized clinical trial. J Infect Dis. 2022 doi: 10.1093/infdis/jiac327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac327</ArticleId><ArticleId IdType="pmc">PMC10044090</ArticleId><ArticleId IdType="pubmed">35904987</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>